Lipid nanoparticles research closing in on genetic treatments for hereditary lung disease, vision loss
Lipid nanoparticles research closing in on genetic treatments for hereditary lung disease, vision loss

phys.org
Lipid nanoparticles research closing in on genetic treatments for hereditary lung disease, vision loss

Unlike other types of lipid nanoparticles that tend to accumulate in the liver, the ones in this study, based on the compound thiophene, are able to navigate their way to the tissues of the lungs and retina, where they deliver their therapeutic payload. The researchers refer to these new lipids as Thio-lipids.